';
CLOSE
Authors Posts by Jason Snyder

Jason Snyder

307 POSTS 0 COMMENTS

0 1095

The Pennsylvania Department of Drug and Alcohol Programs (DDAP) announces a new grant initiative funding opportunity. DDAP is accepting applications from entities with the capacity to deliver employment support services to individuals in recovery from Substance Use Disorder (SUD) seeking to enter the workforce. Employment support services under this project include but are not limited to: vocational assessments, resume writing, interviewing skills, job placement, and transportation assistance related to employment. Applicants shall identify at least one employer partner that is committed to providing employment opportunities to individuals in recovery from SUD.

Applications are due by Monday, May 17, 2021 at 12:00pm. More information is available on DDAP’s website.

0 927

RCPA’s Drug & Alcohol Division has established a Medication Subcommittee. As medication becomes more integral to the addiction treatment system, RCPA members have an opportunity to influence medication-related policy through their experience and expertise. Consider:

  • Access to and integration of medications to treat addiction at all levels of care has become a priority in Pennsylvania.
  • Acceptance of medication as an integral part of treatment continues to grow, especially in areas historically reluctant to embrace it, including criminal justice.
  • The COVID pandemic has changed the treatment landscape, ushering in telehealth and the promise of broader access to care, including medication.

In considering access and integration challenges, regulations, reimbursement, best practice, research, and provider experience, this subcommittee will set an agenda and work with RCPA leadership, other RCPA members, state regulators, payers, legislators, and other key stakeholders to advance that agenda.

Your expertise is invaluable in helping the treatment provider community set this agenda and achieve its goals. If you are interested in participating in the Medication Subcommittee, please email Jason Snyder, Director, RCPA Drug & Alcohol Division.

0 1012

The Pennsylvania Department of Drug and Alcohol Programs (DDAP), along with the Liberty Mid-Atlantic High Intensity Drug Trafficking Area, will again hold a virtual Psychostimulant Symposium December 1–2, 2021. The data continue to show a need for this interdisciplinary information sharing. Feedback from last year’s event was overwhelmingly positive, a direct result of the many excellent speakers and presenters.

Dates: December 1–2, 2021

Format: This is proposed as a one and a half-day virtual event featuring plenary and breakout sessions.

Overview: Both public health and public safety professionals require additional training and information to more readily detect these substances and better respond to psychostimulant overdose victims, and treatment professionals require additional tools to effectively treat patients who misuse psychostimulants. Strategies essential for detecting surges in psychostimulant supply and consumption can aid policymakers and agency leaders in directing resources where most needed.

Target Audience: Law enforcement, criminal justice, health care providers, emergency medical services personnel, drug and alcohol prevention and treatment providers, Single County Authorities (SCAs), government officials, public health professionals, harm-reduction organizations and other interested stakeholders.

Registration: Attendance is free, but pre-registration will be required and limited. More information will be forthcoming.

More Information: Please visit our web page for information about our 2019 and 2020 PA Psychostimulant Symposium.

Proposals to present at this year’s event or questions can be submitted by emailing PA Psychostimulant Symposium on or before June 1, 2021. Proposals should include:

  • Proposed topic
  • Relevance of topic
  • Presenter knowledge/credentials
  • Engagement strategies

0 880

Since submitting the final-omitted regulatory package to the Independent Regulatory Review Commission (IRRC) on March 15, 2021, the Department of Drug and Alcohol Programs (DDAP) has continued to hear concerns with the regulations for the licensure of recovery houses.

To thoroughly review these concerns with interested parties, DDAP has withdrawn the regulations. They are no longer on the agenda for the IRRC public hearing on April 15, 2021. DDAP plans to resubmit the regulations in the near future.

More information on drug and alcohol recovery house licensing is available on DDAP’s website.

0 866

The Department of Drug and Alcohol Programs (DDAP) announced today the availability of $2.7 million in funding for Recovery Community Organizations (RCOs) to expand or enhance recovery support services to individuals in recovery from substance use disorder.

“Community is one of the four dimensions that support and sustain life in recovery,” said DDAP Secretary Jen Smith. “By providing communities with appropriate support services, we can help individuals and their loved ones be better suited for their recovery journey and ultimately live happy, healthy lives.”

The grants are part of $55 million in federal funding awarded to Pennsylvania through the Substance Abuse and Mental Health Services Administration’s (SAMHSA) Substance Abuse Prevention and Treatment Block Grant Program COVID-19 Supplemental Awards. The funding spending plan submitted by DDAP is currently pending approval by SAMHSA. More information will be shared about this funding and supporting projects as it becomes available.

To read about applying for the grants, visit DDAP’s website.

0 1469

The Centers for Disease Control and Prevention (CDC) and the Substance Abuse and Mental Health Services Administration (SAMHSA) announced today that federal funding may now be used to purchase rapid fentanyl test strips (FTS) in an effort to help curb the dramatic spike in drug overdose deaths largely driven by the use of strong synthetic opioids, including illicitly manufactured fentanyl. Unfortunately in Pennsylvania, fentanyl test strips are considered drug paraphernalia and are therefore illegal.

FTS can be used to determine if drugs have been mixed or cut with fentanyl, providing people who use drugs and communities with important information about fentanyl in the illicit drug supply so they can take steps to reduce their risk of overdose.

The entire press release is available on SAMHSA’s website.

0 1130

The Pennsylvania Department of Drug and Alcohol Programs (DDAP) continues to receive comments and questions regarding its Final-Omitted Regulation on Standards for Drug and Alcohol Recovery House Licensure. DDAP’s responses to these concerns are available here for review. These regulations are on the agenda for the Independent Regulatory Review Commission’s (IRRC’s) April 15, 2021 public meeting.

Please note that any comments or questions received by DDAP or IRRC in response to this communication, or in response to the final-omitted regulation, will be forwarded and uploaded to IRRC’s website for consideration by IRRC. Additional information on drug and alcohol recovery house licensing is also available here.

Prev1...282930...31Next Page 29 of 31
© 2021 - Rehabilitation & Community Providers Association